Agilent Shares Jump on Strong Q2, Raised Guidance

Agilent Technologies reported stronger-than-expected second-quarter results, posting adjusted earnings per share of $1.31 and revenue of $1.67 billion, both surpassing analyst forecasts. Growth was driven by the Life Sciences and Diagnostics Markets Group, which achieved an 8% year-over-year revenue increase, and the CrossLab Group. The company raised its full-year 2025 revenue guidance to $6.73–$6.81 billion, while maintaining its adjusted EPS outlook at $5.54–$5.61. These developments led to a 5% increase in Agilent’s share price during after-hours trading and a 2.52% gain during the regular session, outperforming the broader market. Management attributed the positive results to its Ignite Transformation initiative. The strong quarterly performance and improved guidance appear to have restored investor confidence following a period of underperformance.